{"id":"https://openalex.org/W1990378074","doi":"https://doi.org/10.12968/bjca.2015.10.2.66","title":"Developments and risk analysis in anticoagulation","display_name":"Developments and risk analysis in anticoagulation","publication_year":2015,"publication_date":"2015-02-02","ids":{"openalex":"https://openalex.org/W1990378074","doi":"https://doi.org/10.12968/bjca.2015.10.2.66","mag":"1990378074"},"language":"en","primary_location":{"id":"doi:10.12968/bjca.2015.10.2.66","doi":"https://doi.org/10.12968/bjca.2015.10.2.66","is_oa":false,"landing_page_url":"https://doi.org/10.12968/bjca.2015.10.2.66","pdf_url":null,"source":{"id":"https://openalex.org/S83245930","display_name":"British Journal of Cardiac Nursing","issn_l":"1749-6403","issn":["1749-6403","2052-2207"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310321016","host_organization_name":"MA Healthcare","host_organization_lineage":["https://openalex.org/P4310321016"],"host_organization_lineage_names":["MA Healthcare"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Cardiac Nursing","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5087626274","display_name":"Nazish Khan","orcid":"https://orcid.org/0000-0003-4483-7390","observed_orcids":["https://orcid.org/0000-0003-4483-7390"]},"institutions":[{"id":"https://openalex.org/I4210154310","display_name":"The Royal Wolverhampton NHS Trust","ror":"https://ror.org/05pjd0m90","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210154310"]},{"id":"https://openalex.org/I4210154635","display_name":"Wolverhampton Hospital","ror":"https://ror.org/04d7nv189","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210109172","https://openalex.org/I4210154635"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Nazish Khan","raw_affiliation_strings":["Principal Pharmacist, Cardiac Services, Royal Wolverhampton Hospital, Wolverhampton, West Midlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Principal Pharmacist, Cardiac Services, Royal Wolverhampton Hospital, Wolverhampton, West Midlands","institution_ids":["https://openalex.org/I4210154310","https://openalex.org/I4210154635"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5087626274"],"corresponding_institution_ids":["https://openalex.org/I4210154310","https://openalex.org/I4210154635"],"apc_list":null,"apc_paid":null,"fwci":0.8735,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.80752715,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":95},"biblio":{"volume":"10","issue":"2","first_page":"66","last_page":"73"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10285","display_name":"Venous Thromboembolism Diagnosis and Management","score":0.8345000147819519,"subfield":{"id":"https://openalex.org/subfields/2724","display_name":"Internal Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10285","display_name":"Venous Thromboembolism Diagnosis and Management","score":0.8345000147819519,"subfield":{"id":"https://openalex.org/subfields/2724","display_name":"Internal Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10065","display_name":"Atrial Fibrillation Management and Outcomes","score":0.10360000282526016,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10881","display_name":"Blood Coagulation and Thrombosis Mechanisms","score":0.05350000038743019,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/anticoagulation","display_name":"anticoagulation","score":0.9520000219345093},{"id":"https://openalex.org/keywords/vitamin-k-antagonists","display_name":"vitamin K antagonists","score":0.7919999957084656},{"id":"https://openalex.org/keywords/warfarin","display_name":"warfarin","score":0.9990000128746033},{"id":"https://openalex.org/keywords/low-molecular-weight-heparin","display_name":"low molecular weight heparin","score":0.9760000109672546},{"id":"https://openalex.org/keywords/unfractionated-heparin","display_name":"unfractionated heparin","score":0.9900000095367432},{"id":"https://openalex.org/keywords/oral-anticoagulants","display_name":"oral anticoagulants","score":0.8690000176429749},{"id":"https://openalex.org/keywords/parenteral-anticoagulants","display_name":"parenteral anticoagulants","score":0.9990000128746033},{"id":"https://openalex.org/keywords/risk-analysis","display_name":"risk analysis","score":0.5440000295639038}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9261260032653809},{"id":"https://openalex.org/C2776301958","wikidata":"https://www.wikidata.org/wiki/Q407431","display_name":"Warfarin","level":3,"score":0.7323892712593079},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.709057092666626},{"id":"https://openalex.org/C2993590494","wikidata":"https://www.wikidata.org/wiki/Q182338","display_name":"Vitamin k","level":2,"score":0.6268659234046936},{"id":"https://openalex.org/C2778205648","wikidata":"https://www.wikidata.org/wiki/Q215118","display_name":"Anticoagulant","level":2,"score":0.6024855375289917},{"id":"https://openalex.org/C2777557582","wikidata":"https://www.wikidata.org/wiki/Q190016","display_name":"Heparin","level":2,"score":0.5588852167129517},{"id":"https://openalex.org/C2776884760","wikidata":"https://www.wikidata.org/wiki/Q2750727","display_name":"Low molecular weight heparin","level":3,"score":0.5121829509735107},{"id":"https://openalex.org/C2992750412","wikidata":"https://www.wikidata.org/wiki/Q215118","display_name":"Oral anticoagulant","level":4,"score":0.48561134934425354},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.24438625574111938},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.12685751914978027},{"id":"https://openalex.org/C2779161974","wikidata":"https://www.wikidata.org/wiki/Q815819","display_name":"Atrial fibrillation","level":2,"score":0.11900997161865234}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.12968/bjca.2015.10.2.66","doi":"https://doi.org/10.12968/bjca.2015.10.2.66","is_oa":false,"landing_page_url":"https://doi.org/10.12968/bjca.2015.10.2.66","pdf_url":null,"source":{"id":"https://openalex.org/S83245930","display_name":"British Journal of Cardiac Nursing","issn_l":"1749-6403","issn":["1749-6403","2052-2207"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310321016","host_organization_name":"MA Healthcare","host_organization_lineage":["https://openalex.org/P4310321016"],"host_organization_lineage_names":["MA Healthcare"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Cardiac Nursing","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":21,"referenced_works":["https://openalex.org/W70145905","https://openalex.org/W72873132","https://openalex.org/W1975650244","https://openalex.org/W1997101311","https://openalex.org/W1999468381","https://openalex.org/W2016875529","https://openalex.org/W2095901832","https://openalex.org/W2097854437","https://openalex.org/W2100028029","https://openalex.org/W2114758846","https://openalex.org/W2129241155","https://openalex.org/W2131387075","https://openalex.org/W2136489990","https://openalex.org/W2140607855","https://openalex.org/W2156927593","https://openalex.org/W2159730165","https://openalex.org/W2162508946","https://openalex.org/W2164861810","https://openalex.org/W2172245650","https://openalex.org/W2202544074","https://openalex.org/W3030533492"],"related_works":["https://openalex.org/W2326181052","https://openalex.org/W2126518073","https://openalex.org/W2772002321","https://openalex.org/W2511946343","https://openalex.org/W2059535421","https://openalex.org/W4393094957","https://openalex.org/W2067880085","https://openalex.org/W4248263978","https://openalex.org/W2990111757","https://openalex.org/W2406144252"],"abstract_inverted_index":{"The":[0],"indications":[1,29],"for":[2,23,50],"which":[3],"an":[4,74],"anticoagulant":[5,55],"may":[6],"be":[7],"prescribed":[8,22],"have":[9],"remained":[10],"largely":[11],"unchanged.":[12],"However,":[13],"until":[14],"recently,":[15],"the":[16,24,31,42,47,61,88],"only":[17],"drugs":[18],"that":[19],"were":[20,30],"routinely":[21],"management":[25],"of":[26,63,66,76],"these":[27],"diverse":[28],"vitamin-K":[32],"antagonists":[33],"(namely":[34],"warfarin),":[35],"unfractionated":[36],"and":[37,53,81,83,90],"low-molecular-weight":[38],"heparin":[39],"(LMWH).":[40],"In":[41],"last":[43],"5":[44],"years":[45],"alone,":[46],"pharmacological":[48],"landscape":[49],"both":[51,79],"oral":[52,80],"parenteral":[54],"therapy":[56],"has":[57],"changed":[58],"considerably":[59],"following":[60],"introduction":[62],"a":[64],"number":[65],"new":[67],"therapeutic":[68],"agents.":[69],"This":[70],"article":[71],"will":[72],"provide":[73],"overview":[75],"available":[77],"anticoagulants,":[78],"parenteral,":[82],"give":[84],"some":[85],"insight":[86],"into":[87],"advantages":[89],"disadvantages":[91],"associated":[92],"with":[93],"their":[94],"use.":[95]},"counts_by_year":[{"year":2015,"cited_by_count":2}],"updated_date":"2026-05-21T06:26:12.895304","created_date":"2016-06-24T00:00:00"}